Jamie Clark
Stock Analyst at Rothschild & Co
(2.61)
# 2,237
Out of 5,090 analysts
9
Total ratings
85.71%
Success rate
10.62%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jamie Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WST West Pharmaceutical Services | Initiates: Buy | $311 | $280.23 | +10.98% | 1 | Sep 15, 2025 | |
| MEDP Medpace Holdings | Downgrades: Neutral | $342 → $474 | $548.12 | -13.52% | 1 | Sep 3, 2025 | |
| ICLR ICON Public Limited Company | Upgrades: Buy | $184 → $236 | $185.80 | +27.02% | 1 | Sep 3, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $188 → $182 | $184.31 | -1.25% | 3 | May 23, 2025 | |
| LH Labcorp Holdings | Initiates: Buy | $276 | $258.39 | +6.82% | 1 | Apr 2, 2025 | |
| DGX Quest Diagnostics | Initiates: Buy | $195 | $182.51 | +6.84% | 1 | Apr 2, 2025 | |
| IQV IQVIA Holdings | Initiates: Buy | $276 | $225.85 | +22.21% | 1 | Oct 14, 2024 |
West Pharmaceutical Services
Sep 15, 2025
Initiates: Buy
Price Target: $311
Current: $280.23
Upside: +10.98%
Medpace Holdings
Sep 3, 2025
Downgrades: Neutral
Price Target: $342 → $474
Current: $548.12
Upside: -13.52%
ICON Public Limited Company
Sep 3, 2025
Upgrades: Buy
Price Target: $184 → $236
Current: $185.80
Upside: +27.02%
Charles River Laboratories International
May 23, 2025
Upgrades: Buy
Price Target: $188 → $182
Current: $184.31
Upside: -1.25%
Labcorp Holdings
Apr 2, 2025
Initiates: Buy
Price Target: $276
Current: $258.39
Upside: +6.82%
Quest Diagnostics
Apr 2, 2025
Initiates: Buy
Price Target: $195
Current: $182.51
Upside: +6.84%
IQVIA Holdings
Oct 14, 2024
Initiates: Buy
Price Target: $276
Current: $225.85
Upside: +22.21%